The important question around this telehealth pharmacy is practical: what is actually known, what remains uncertain, and what safeguards a licensed clinician and pharmacy process add before anyone treats it as an option.
The eating protocol I built in month four was the one that finally fit the medication. Everything before that was just trying to shove old habits into a body that no longer worked the same way.
I remember standing in my kitchen in month two, staring at a meal-prepped row of containers, five chicken-and-rice bowls lined up in the fridge like soldiers. It was a Tuesday. I’d made them Sunday night, the same routine I’d followed for years when I was “being good.” By Tuesday, I’d eaten half of one. Not because I was being disciplined. Because the sight of them made my stomach tighten. My friend Rachel, who’d started compounded semaglutide about six weeks ahead of me in Austin, had warned me on the phone: “Throw out whatever playbook you had before. You’re eating for a different person now.” She was eating maybe 1,300 calories a day, hitting 95 grams of protein, and feeling better than she had in a decade. I didn’t listen. Not until month four.
Compounded semaglutide is not FDA-approved. It is prepared by licensed compounding pharmacies for individual patients under a prescriber’s order. The clinical literature on the branded products is the strongest available reference for what the molecule does in the body, including its effects on appetite and food preference. The eating protocol described here is one patient’s account, not a clinical recommendation.
What Semaglutide Actually Does to Your Hunger
Here’s the thing about appetite on this medication: it doesn’t vanish. It transforms.
The patient-level experience, and this tracks with the published trial data, is an earlier and stronger satiety signal, a general dimming of food interest, and a quiet rearrangement of preferences. Protein and simple carbs start to feel appealing. Rich, greasy, or heavily sweetened food starts to feel like a chore. Some people describe it as the disappearance of “food noise,” that background hum of thinking about your next meal. Others call it a clean appetite, something closer to what hunger probably should have felt like all along.
What it does not do is tell you how to eat. The medication opens a door. You still have to furnish the room.
Why My Old Diet Framework Fell Apart
My pre-medication eating strategy was, like most people’s, a willpower architecture. It was engineered around managing hunger and white-knuckling past cravings. Meal timing, calorie banking, “good days” and “bad days.” The entire vocabulary was about resistance.
The medication had already handled the resistance problem. Trying to apply the old system anyway produced two predictable failures.
First: undereating. My defaults were calibrated for a body that was perpetually hungry. Applied to a body that wasn’t, those defaults produced calorie intakes that were dangerously thin. I was hitting 800 calories on some days without realizing it. Second: pointless restriction. The old framework was obsessed with what to avoid. On semaglutide, there was barely anything I was drawn to in the first place. Adding restriction on top of suppressed appetite is like putting a lock on an already-empty safe.
The first three months, the weight came off. But I was losing the wrong kind of weight, and I could feel it. Low energy. Flat workouts. The kind of tired that sleep doesn’t fix.
Building the Protocol Around the Actual Appetite
The eating pattern that finally worked started from a simple premise: feed the appetite the medication actually produces, instead of fighting it or ignoring it.
The structure I landed on was three small meals plus a structured snack. Each meal had a protein anchor. Each meal had a vegetable. Each had a small portion of starch or fat. The snack was usually Greek yogurt with fruit, or a handful of almonds and an apple. Total daily intake landed around 1,400 calories, with roughly 100 grams of protein.
It was boring. Five or six meals on rotation, seasonal vegetables swapped in, occasional variations on weekends. The repetition was the feature. On a small and somewhat unpredictable appetite, the meals that come together in seven minutes are the meals that actually get eaten. Anything requiring ambition at the stove was a meal that wouldn’t happen.
The provider I was working with, this telehealth pharmacy, shared a similar framing in their patient materials, and it matched what I was figuring out on my own.
The Protein Problem Is Bigger Than You Think
The protein target was the piece I didn’t take seriously enough in the early months. The published clinical literature on GLP-1 therapy has discussed the lean-mass question extensively, and the data is sobering: a meaningful share of the weight lost during early-phase treatment can be lean mass, not just fat. The patient interventions that protect against that are protein intake and resistance training.
I settled on roughly a gram per pound of goal body weight. For me, that was about 100 grams a day. Harder than it sounds. With a compressed appetite, volume eating is impractical. Protein-dense foods became the only realistic path.
The roster: Greek yogurt, cottage cheese, chicken breast, ground turkey, eggs, and (reluctantly) a once-daily whey protein shake. I’d resisted the shake for a long time, mostly out of some vague sense that shakes were for gym bros. On the medication, it became the simplest way to add 25 grams of protein to a day that was running short. Vanity is a luxury you can’t afford when you’re protecting muscle.
Carbs, Hydration, and the Stuff I Learned the Hard Way
The carbohydrate question sorted itself out through trial and error. My old instinct was to minimize carbs as aggressively as possible. That framing didn’t fit. What my body actually wanted was small portions of simple starches that sat well on a reduced appetite. Brown rice. Sweet potato. A piece of bread with the right meal. The total carb intake was modest, but the mindset shifted from avoidance to pairing. Research suggests that the composition of an eating pattern matters less for weight outcomes than the consistency of the eating pattern. My experience tracked that exactly.
Hydration was the lesson I paid for in headaches. The reduced appetite meant less water from food. The early-phase nausea meant less plain water going down willingly. The combination produced a low-grade dehydration in month two that I didn’t identify until it was causing fatigue and a persistent dull headache behind my eyes. The fix was switching most of my fluid intake to electrolyte drinks for a few weeks until the nausea settled. After month three, plain water became manageable again. The electrolyte drinks were a bridge, not a lifestyle.
What Actively Made Things Worse
Worth naming what didn’t work, because I tried all of it.
Strict macro counting didn’t work on the medication. The appetite was too variable day to day to make the numbers reliable, and the tracking itself became a source of anxiety rather than information. Intermittent fasting didn’t work. Compressing an already-small appetite into a narrow eating window produced calorie intakes so low they felt dangerous. Strict avoidance protocols didn’t work. The appetite was already suppressed enough that adding more restriction produced undereating, not discipline.
My honest opinion: most of the popular diet frameworks people bring to GLP-1 therapy are designed for a problem the medication has already solved. Applying them is like wearing a winter coat indoors because you packed it for the trip.
What I’d Tell Someone Starting Month One
The eating pattern that worked for me was the one that respected what the medication had actually done to my appetite. Simple. Repetitive. Built around protein and consistency. The frameworks I brought in from before didn’t fit, and trying to force them cost me three months of suboptimal results and unnecessary fatigue.
The patient who builds the eating pattern from the medication’s actual effects, rather than from whatever diet they were running before, tends to have a much easier time in months four through twelve. Rachel was right. Throw out the old playbook.
Frequently Asked Questions
How many calories should I eat on semaglutide? There’s no universal number. For me, 1,400 calories with about 100 grams of protein was sustainable. Some patients land higher, some lower. The key is that the intake should be deliberate, not just whatever you happen to eat because your appetite is suppressed. Undereating is a real risk on this medication.
Do I need to count macros on semaglutide? Not necessarily. Strict macro counting didn’t work for me because appetite variability made the numbers unreliable from day to day. A simpler approach, anchoring each meal around protein with a vegetable and a small starch, got me to roughly the same place with less friction.
Can I do intermittent fasting while on compounded semaglutide? I tried it. It compressed an already-small appetite into too few eating hours and produced dangerously low calorie days. That’s a common pattern. Most providers I’ve spoken with recommend spreading meals across the day rather than restricting the window.
Why is protein so important on GLP-1 medications? Published clinical data shows that a significant portion of weight lost during early GLP-1 therapy can be lean mass. Adequate protein intake (along with resistance training) is the primary intervention that protects against lean-mass loss. Missing the protein target is probably the most common nutritional mistake on these medications.
What should I do about nausea affecting my eating? Early-phase nausea is common and tends to settle after the first few months. Smaller, more frequent meals help. Electrolyte drinks can bridge the hydration gap when plain water is hard to tolerate. If nausea is persistent or severe, that’s a conversation for your prescriber, not something to just push through.
Is compounded semaglutide the same as brand-name semaglutide? Compounded semaglutide is not FDA-approved and is prepared by licensed compounding pharmacies for individual patients under a prescriber’s order. The active molecule is the same, but compounded versions have not undergone the same regulatory review as branded products. The clinical evidence base is built on the branded formulations.
